Incoming Pump to $4DRRX is nearing a breakout on a well established trend line. Short term this could go up to $3.50. Long term on a monthly swing trade we could see $10. Volatility incoming. Keep in mind it could always ride the trend line lower. Waiting for confirmation reduces risk.Longby JohnnySecretzPublished 0
HELLO guys good position to entery $DRRX for LONG $DRRX long time corrective wave ended by elliot wave count WXYXZ. by JobirPublished 110
DRRX LongSideway near support line OBV>OBV34 WR crossed -80 Entry 1.7 Stop 1.5 Target 3.8 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.Longby PlanTradePlanMMUpdated 3
A bottoming pattern??Hi! So this one came up and I thought I would see the good sides of this. This is a longer, potential week or 2 trade (Could be shorter too! Haha!)Longby eshemutaUpdated 1
DRRX - 100% GAINS - BREAKING OUT- DRRX COMING UP OFF DEMAND ZONE - BREAKOUT OF CONSOLIDATION AT APEX OF TRIANGLE - TARGET #1 = 100% UP - TARGET #2 = $5.10 (160% GAIN)Longby ChasingTheMoonPublished 3
Bullish Charts - Huge Earrings BeatDURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for pharmaceutical and medical device clients for use as raw materials in their products under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase I and II development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's oral and injectable delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Zogenix, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California. This morning Durect reported earrings that blew away Wall Street Estimates. Q2 EPS $0.07 Up From $(0.04) YoY, Sales $25 Million Beat $11.48 Million Estimate Sales more than doubled estimates. Daily Chart is Bullish Indicators are rising, Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Longby HotChartsPublished 3
DURECT Corporation Announces Positive Topline Data from Phase 1bDRRX: DURECT Corporation 2020-05-26 08:30:00 DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASHLongby JetEquitiesPublished 3
DRRX best Penny stocks for March The next one the next one is some of you pro bably remembered DRRX , these stocks for folks who are serious and want to trade price action and the truth is that as traitors we really couldn't careless we don't give a hoot about what happens to a dog after we take our price friend after me repeat after me who cares if it's be down afterwards am I right just fell out and validation and we don't even need it to be a good company we just need people to think that is a good company so we can exploit the opportunity of the run-up to the big spike the last fight for small in comparison but the last year was on an announcement that they had issued which will eventually culminating in a new approval date we are waiting for an announcement on a date or really needs to drop us to trade the price Trading quite low I just making sure that were getting any good deal or continuing to be a good day before you actually take your entry point that very important Longby UnknownUnicorn6877177Published 116
Durect Corp bounces off Support DURECT Corp. is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA. by DEXWireNewsPublished 22
DRRX bullish.After a double bottom and what looks like a pennant, we could see a breakout to newer highs. Sorry, I didn't spend a lot of time on this chart. Support around 1.86 - 1.88Longby AdamWestUpdated 2
DRRX, I'm inBy looking at the indicators I use DRRX looks ready to go up. I've placed my order to be filled on Nov 12th. Let's see how this one goes. Purple line signifies my purchase date. All other indicators are positive for upward trend. Looks strong to me.Longby mattisbaseballPublished 223
DURECT CORP - NASDAQ: $DRRX FlaggingAfter breaking to higher ground a week ago on enormous volume, shares of DURECT CORP - NASDAQ:DRRX finds themselves consolidating the recent thrust in a Flag pattern on lower volume as we can observe from the Daily chart above. In addition, DRRX is now trading above all of its important moving averages 20/50/200 DMA's, which from a technical perspective, is healthy as well as constructive. Both investors/traders may want to continue to monitor the action closely in the days/weeks ahead as we believe that its only a matter of time before the stock comes up-and-out of its Flag with its sights set on greener pastures. Thus, investors/traders may want to put DRRX front-and-center on their radars as we're anticipating a potential move into the $1.40 - $1.60 zone (and potentially higher) should the stock pop out of its pattern within the days/weeks ahead. ****NOTE DURECT Corporation - NASDAQ:DRRX to Announce Second Quarter 2019 Financial Results on August 1, 2019 After Market Close **** by InsiderFinancialUpdated 7
DRRX- Double bottom Fallen angel Long from 1.12 to 1.28 & 1.47 DRRX bouncing off its longterm support after a huge decline. Now it seems forming nice fallen angel formation with a higher low double bottom. We think it has good upside potential from here. * Trade Criteria * Date First Found- November 21, 2017 Pattern/Why- Fallen angel, Double bottom Entry Target Criteria- Break of $1.12 Exit Target Criteria- 1st Target $1.28, 2nd Target $1.47 Stop Loss Criteria- $ 0.97 Please check back for Trade updates. (Note: Trade update is little delayed here.)Longby AcornWealthCorpPublished 113
BUY [DRRX]LONG After market crashed due to negative news. Price is back to 0.78 from nearly 2.00. More downside is always a possibility, but this drop went directly to prior support area. Expecting support to hold, and for price to continue long for a correction in the market. Longby MarketMastersYouTubeUpdated 4
DRRX approaching target set on July 3DRRX approaching target set on July 3by Pivotal_CapitalPublished 4
DRRX- buy Jan2017_2.5 CallDRRX breaking up a symmetrical triangle & same for money-flow. Technically it looks good so we took some speculative Jan2017- 2.5 Option calls. You can check our detailed analysis on _ in the trading room/ Executive summery link here- www.youtube.com Time Span: 6:40” Trade Suggestion Date: 12th Jul Trade Status: Opened (12th Jul) Jan2017- 2.5 call for $0.35 Longby AcornWealthCorpPublished 3
DRRX continuation or breakout Possible Reverse pattern from bearish to Bullish Wait and See...Longby LiaoTaiLungUpdated 1